Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology
K Anderson1, A Potter, D Baban
1Department of Human Anatomy and Genetics, University of Oxford, South Parks Road, Oxford OX1 3QX, UK.
Brain : a Journal of Neurology
|July 9, 2003
Summary
Spinal muscular atrophy (SMA) is a motor neuron disease linked to the SMN gene. This study reveals altered transcription factor pathways in SMA, suggesting their down-regulation contributes to motor neuron loss.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Autosomal recessive proximal spinal muscular atrophy (SMA) is a severe childhood neurodegenerative disease.
- Motor neuron dysfunction leads to muscle weakness and wasting in SMA patients.
- Over 97% of SMA cases stem from mutations in the survival motor neuron (SMN) gene.
Purpose of the Study:
- To investigate differences in protein expression patterns in muscle cultures from SMA patients compared to controls.
- To identify potential molecular pathways altered in SMA pathogenesis.
- To explore the role of RNA binding proteins and transcription factors in SMA.
Main Methods:
- Utilized novel antibody array technology to analyze protein expression in primary muscle cultures.
- Confirmed protein expression changes using Western blot analysis in muscle samples.
- Assessed mRNA level changes with oligonucleotide arrays.
Main Results:
- Identified differences in proteins functioning as both RNA binding proteins and transcription factors.
- Found interactions between identified proteins, including connections to p53 and SMN.
- Confirmed changes at both protein and mRNA levels in SMA patient samples.
Conclusions:
- Suggests a common transcription pathway may be altered in SMA.
- Indicates that down-regulation of transcription factors contributes to SMA pathogenesis.
- Highlights the potential involvement of RNA binding proteins and transcription factors in motor neuron loss in SMA.
